tl;dr <i>"Oncologist Samir Parekh and his colleagues at the Mount Sinai Icahn School of Medicine in New York wanted to change the treatment paradigm in multiple myeloma. So they developed a system that uses an algorithm to match up multiple myeloma patients with drugs that are already on the market to treat other cancers. They tried the resulting recommendations in a group of 21 patients with treatment-resistant multiple myeloma and got positive results in all but five—a response rate that’s so high Parekh believes the idea could be extended to many other cancers."</i><p>The title makes it sound like what IBM aspired to do, but it's more of a statistical algorithm than "AI".